Although less prevalent overall in gliomas compared to the mutually exclusive TERT promoter mutations, ATRX mutations and ALT are frequent in specific molecular subgroups of sporadic brain tumors, particularly IDH mutant astrocytomas [4,10]. Here, ATRX is linked to central nervous system cancer.